Bill of Health

APRIL 7, 2022

On March 15, 2022, STAT published text of a proposed compromise at the World Trade Organization (WTO) to temporarily relax global standards for intellectual property for COVID-19. In short, the compromise only waives a single 20-word paragraph in one article: the one dealing with exports under a non-voluntary authorization.

COVID-19 363

COVID-19 COVID-19 Vaccine Licensing Public Health 363

Bill of Health

SEPTEMBER 13, 2022

Americans are no doubt conditioned to expect spectacular failure in the face of public health crises. The United States had been ravaged for decades by a shape-shifting drug overdose crisis before the emergence of COVID-19. Just as COVID-19 deaths in the U.S. Just as COVID-19 deaths in the U.S.

Public Health 237

Public Health COVID-19 Governance Health Outcomes 237

Healthcare IT Today

JANUARY 13, 2023

Consolidating and coordinating information between providers, payers and public health departments is particularly tough, not only because there are so many providers, but because of the variability between data platforms and systems. In recent years, some states leveraged the power of HIEs to identify COVID-19 hotspots in communities.

US Department of Health and Human Services 61

US Department of Health and Human Services COVID-19 Public Health Nursing Homes 61

HIT Consultant

NOVEMBER 23, 2022

The early 2020s will be studied by historians as a time of global uncertainty when an unknown pathogen caused a public health emergency that brought the world to the brink. So, what other than advances in diagnostic technology, has the experience of Covid given us? Here are just a few examples. Artificial Intelligence .

COVID-19 52

COVID-19 Public Health Nursing Homes Hospitals 52

SQA

APRIL 30, 2021

Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19 Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19 vaccine exports. The mechanism provides for authorizations of exports of COVID-19 vaccines outside the EU.

COVID-19 Vaccine 52

COVID-19 Vaccine COVID-19 Compliance Governance 52

SQA

SEPTEMBER 2, 2022

ANVISA published the RDC 702/2022, which repeals some requirements that were instituted to speed market approval of devices needed to treat patients during the height of the COVID-19 pandemic. The Agency recently published the first list of critical medicines for the management of the COVID-19 pandemic.

FDA 91

FDA COVID-19 Nursing Homes Compliance 91

SQA

DECEMBER 16, 2022

ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. 19 Medical Rehabilitation Equipment. It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities. CMDE Announcement No.

FDA 40

FDA Compliance COVID-19 Licensing 40